Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

18 Dec, 2018, 15:00 GMT Ajinomoto and XL-protein Forge Strategic Alliance to Develop PASylated Therapeutics Applying the Corynex® Platform

Ajinomoto Bio-Pharma Services, a fully owned subsidiary of Ajinomoto Co. Inc. (TSE: 2802), and XL-protein GmbH, a privately owned German...


18 Dec, 2018, 11:08 GMT URGO Group Receives the ‘Prix Galien France 2018’ for UrgoStart®, an Innovative Treatment for Diabetic Foot Wound Healing

URGO Group, through its Urgo Medical division, received the Prix Galien France 2018 in the medical device category for UrgoStart®, the first dressing ...


18 Dec, 2018, 10:26 GMT Indivumed Announces an International Partnership With IMCB to Establish an Asian-Centric Multiomics Cancer Database for Personalized Oncology

Indivumed GmbH today announced the launch of the "Cancer Library Initiative", an operation to further accelerate precision diagnostics and...


17 Dec, 2018, 14:00 GMT Volcani Center Announces Significant Breakthroughs in CTCL Skin Cancer Cannabis Treatment Development in Cooperation With MedC Biopharma Corporation of Canada

Volcani Center announces today its preparation of patents for the treatment of Cutaneous T cell lymphoma (CTCL), a class of non-Hodgkin lymphoma - a...


17 Dec, 2018, 13:00 GMT Sangamo Announces Treatment Of First Patient In Phase 1/2 Clinical Trial Of In Vivo Genome Editing Therapy For Hemophilia B

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomics medicines company, today announced treatment of the first patient in the Phase 1/2 clinical...


17 Dec, 2018, 07:20 GMT BioNet reports on persistence of antibody responses of recombinant pertussis vaccines in the Lancet Infectious Diseases

BioNet announced today that the one-year antibody persistence results from the phase 2/3 randomized controlled trial of its monovalent and combined...


13 Dec, 2018, 10:00 GMT Transporting the Light Killers: NUST MISiS and MIREA-Russian Technological University Collaborate to Create a Unique Tandem of Organic Molecules and Nanoparticles to Fight Cancer

A team of materials scientists from NUST MISiS together with a team of chemists from MIREA-Russian Technological University have managed to combine a ...


13 Dec, 2018, 07:00 GMT Sosei Heptares Starts New Clinical Development Program - First Subject Dosed in Phase I Study of HTL0014242, a Selective mGlu5 Negative Allosteric Modulator in Development to Treat Psychiatric and Neurological Disorders

Sosei Group Corporation ("the Company"; TSE: 4565), announces that the first healthy subject has been dosed with a novel small molecule HTL0014242 in ...


12 Dec, 2018, 17:34 GMT Lower-Priced Spacer Chambers Could Compromise Young Asthma Patients' Treatment

Presented at the British Thoracic Society December 2018. When spacer chambers were introduced in the 1980s, they were a game changer in asthma...


12 Dec, 2018, 06:30 GMT BerGenBio Presents Key Results From PhII Programme With Selective AXL Inhibitor Bemcentinib at DNB's 9th Annual Nordic Healthcare Conference

BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company focused on developing a pipeline of first-in-class AXL kinase inhibitors to...


11 Dec, 2018, 10:00 GMT Institut Marquès Launch First National Study of Sperm in Ireland

http://www.toxicsarebreakingourballs.ie Environmental pollution with toxic chemicals is the main cause of poor sperm quality Starting today, Irish...


11 Dec, 2018, 09:00 GMT INC Announces New Scientific Evidence Suggesting Dried Fruit May Help Lower Blood Sugar Response

WATCH THE VIDEO: https://youtu.be/o0-oP8dmwC0 Certain dietary patterns, especially those rich in fruits and vegetables, may help decrease the risk of ...


11 Dec, 2018, 07:21 GMT Alligator Bioscience Starts Clinical Phase I Study With ATOR-1015

Alligator Bioscience AB (Nasdaq Stockholm: ATORX) today announces that regulatory approvals have been obtained for the first clinical study of...


10 Dec, 2018, 13:11 GMT New long-term evidence from large study reinforces value of the Oncotype DX Breast Recurrence Score® test to guide adjuvant chemotherapy treatment, confirming TAILORx conclusions

Long-term outcomes data from a large population-based study1, presented at the 2018 San Antonio Breast Cancer Symposium® (SABCS), further support the ...


10 Dec, 2018, 08:00 GMT As Fever in Children Reaches Peak Levels, Research From Nurofen Reveals the Hidden and Wide-reaching Impact That Loss of Sleep in Children With Pain or Fever Can Have

Fever and pain in children can lead to lost or disrupted sleep, anxiety among the family and days of nursery, school or work missed due to illness1...


07 Dec, 2018, 14:39 GMT Cantargia: Phase I Safety Evaluation Part of CANFOUR Trial of Antibody CAN04 Completed and Phase IIa Part Being Initiated

Cantargia AB (publ) today announces that all patients in the phase I part of the CANFOUR clinical trial have completed the formal safety evaluation...


07 Dec, 2018, 06:00 GMT Pharming Reports Favourable Conclusion from First Investigator-initiated Direct Comparative Real-world Study of Acute Hereditary Angioedema Therapies

Treatment with recombinant therapy RUCONEST® and plasma-derived C1 treatments requires significantly less re-dosing than icatibant (Firazyr®) to...


06 Dec, 2018, 14:00 GMT Fimbrion and GSK Identify Novel, Antibiotic-Sparing Development Candidate for Urinary Tract Infections

Fimbrion Therapeutics, Inc. announced that under its joint research collaboration with GSK, researchers have identified an orally available, small...


06 Dec, 2018, 11:34 GMT Emosis and Accellix Announce Intent to Form a Joint Venture, EmoCellix

EmoCellix will focus on marketing a complete solution for hemostasis cytomolecular diagnostics The French company Emosis and Accellix today announced ...


06 Dec, 2018, 07:00 GMT Berlin Cures' Steering Committee is Assembled to Facilitate the Design and Implementation of Phase 2 Study of BC 007

Swiss drug developer Berlin Cures Holding AG today announced the establishment of a steering committee of renowned cardiologists focused on ensuring...


05 Dec, 2018, 23:00 GMT Daiichi Sankyo Presents Updated Phase 1 Data for U3-1402 in Patients with HER3-Expressing Metastatic Breast Cancer at 2018 San Antonio Breast Cancer Symposium (SABCS)

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that updated efficacy and safety results from the ongoing phase 1/2 study of...


05 Dec, 2018, 10:00 GMT DTRA Commits Additional Funds to MeMed's Innovative Bacterial Versus Viral Test and Point-of-Care Platform

MeMed's contract with DTRA is expanded to include key verification milestones MeMed today announced DTRA's expanded commitment to their point-of-care ...


05 Dec, 2018, 07:00 GMT Moorfields Dubai Performs Complex High-risk Surgery to Bring Maths Professor Back From the Brink of Blindness

Moorfields Eye Hospital Dubai (Moorfields Dubai) has performed a complex and high-risk surgical procedure as a last resort to prevent a patient...


04 Dec, 2018, 11:56 GMT TIGR(R)Matrix shows promising results when used for incisional hernia prevention in septic patients undergoing laparoscopy

Onlay mesh placement of the synthetic and fully resorbable TIGR®Matrix surgical mesh (Novus Scientific AB, Uppsala -- Sweden) for the prevention of...


04 Dec, 2018, 06:16 GMT Juntendo University Research: Omega-3 Fatty Acids Suppress Allergic Conjunctivitis Symptoms

Researchers at Juntendo University report in the FASEB Journal that a diet based on omega-3 fatty acids alleviates allergic conjunctivitis in mice....